Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Ropivacaine for Pain After TKA
NCT02616367Phase 2Withdrawn
- Sponsor
- University of Minnesota
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of liposomal bupivacaine in postoperative pain, sponsored by University of Minnesota. Planned start Dec 2015; status: withdrawn.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02616367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02616367.